PubRank

Seiichi Suzuki

Author PubWeight™ 18.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene expression profile in the regenerating rat liver after partial hepatectomy. J Hepatol 2003 2.43
2 Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003 1.73
3 Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 2002 1.59
4 Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J 2002 1.19
5 Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res 2003 0.98
6 Brap2 functions as a cytoplasmic retention protein for p21 during monocyte differentiation. Mol Cell Biol 2004 0.95
7 Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells). J Pharmacol Exp Ther 2002 0.87
8 Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation 2002 0.86
9 Transplantation of amniotic epithelial cells into fetal rat liver by in utero manipulation. Cell Transplant 2002 0.85
10 A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine. Cancer Lett 2002 0.83
11 Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Transpl Immunol 2003 0.82
12 [Possible use of amniotic cells for regenerative medicine]. Nihon Rinsho 2003 0.81
13 Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation. Liver Transpl 2004 0.79
14 Successful transplantation of a 20% partial liver graft in rats: a technical innovation. J Surg Res 2003 0.79
15 Tracking 3D picometer-scale motions of single nanoparticles with high-energy electron probes. Sci Rep 2013 0.77
16 Comprehensive examination of gene expression associated with long-term stable graft acceptance by renal transplant recipients. Clin Transplant 2004 0.76
17 Standardization of ischemic hepatic failure in pigs as a model for bioartificial liver assessment. Surg Today 2003 0.76
18 Catalytic RAG1 mutants obstruct V(D)J recombination in vitro and in vivo. Mol Immunol 2003 0.76
19 Prolongation of transgene expression by coexpression of cytokine response modifier a in rodent liver after adenoviral gene transfer. Mol Ther 2002 0.75
20 AdCTLA-4Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model. Transpl Int 2003 0.75
21 Prolongation of liver xenograft survival by adenovirus vector-mediated CTLA-4Ig gene transfer. Transpl Immunol 2003 0.75
22 Artificial mimicking of physiological active transport by a membrane co-cultured with two different cells: hepatic origin HepG2 and renal origin PCTL-MDR. Artif Organs 2002 0.75
23 [Immunosuppression by gene transfection]. Nihon Rinsho Meneki Gakkai Kaishi 2002 0.75
24 [Regenerative medicine in liver disease]. Nihon Rinsho 2003 0.75
25 AMMONIA REMOVAL ACTIVITY OF AGAROSE-ENCAPSULATED RAT HEPATOCYTES. Cell Transplant 1995 0.75
26 Periodic reciprocating motion of a polymer gel on an aqueous phase synchronized with the Belousov-Zhabotinsky reaction. Langmuir 2014 0.75
27 Simultaneous determination of ionic and neutral preservatives by inline dialysis-ion chromatography coupled with a hydrophobic-ion exchange mixed mode column. Anal Sci 2011 0.75